BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB targets 2x the daily returns of the biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -1.01% 14.41% 41.46% 44.59% 93.99% 35.10% 4.57% 9.35% 18.24% 04/07/2010
BIB Market Price -0.91% 14.69% 41.74% 44.83% 94.28% 35.26% 4.58% 9.38% 18.26% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $93,284,743
  • Gross Expense Ratio
    1.17%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 10/15/2026
  • NAV
    $111.05
  • NAV Change
    $+4.17 up caret
  • Market Price
    $111.11
  • Market Price Change
    $+4.29 up caret
  • Trading Volume (M)
    8,444
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $93,284,743
  • Gross Expense Ratio
    1.17%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 10/15/2026
  • NAV
    $111.05
  • NAV Change
    $+4.17 up caret
  • Market Price
    $111.11
  • Market Price Change
    $+4.29 up caret
  • Trading Volume (M)
    8,444
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2027. Without the fee waiver performance would likely be lower.

Exposures

Index as of 6/30/2026

Holdings

as of 10/15/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.41% GILD GILEAD SCIENCES INC -- $5,046,855.90 32,070 2369174
5.08% AMGN AMGEN INC -- $4,738,305.51 10,917 2023607
4.70% VRTX VERTEX PHARMACEUTICALS INC -- $4,384,916.25 8,619 2931034
3.89% MRNA MODERNA INC -- $3,627,200.50 15,337 BGSXTS3
3.32% REGN REGENERON PHARMACEUTICALS -- $3,093,780.90 3,885 2730190
1.67% RVMD REVOLUTION MEDICINES INC -- $1,558,366.84 8,234 BL71K91
1.67% ILMN ILLUMINA INC -- $1,554,261.93 5,801 2613990
1.43% BIIB BIOGEN INC -- $1,335,846.60 5,676 2455965
1.29% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,202,914.20 5,140 B00FWN1
1.09% RPRX ROYALTY PHARMA PLC- CL A -- $1,019,859.72 17,106 BMVP7Y0
1.01% ROIV ROIVANT SCIENCES LTD -- $944,575.96 27,749 BMW4NZ9
0.96% UTHR UNITED THERAPEUTICS CORP -- $892,408.48 1,648 2430412
0.95% ARGX ARGENX SE - ADR -- $886,890.96 1,048 BDVLM39
0.95% INCY INCYTE CORP -- $882,033.49 7,787 2471950
0.92% GH GUARDANT HEALTH INC -- $855,111.40 5,155 BFXC911
0.89% INSM INSMED INC -- $832,272.69 8,389 2614487
0.86% VTRS VIATRIS INC -- $803,939.28 44,124 BMWS3X9
0.72% MEDP MEDPACE HOLDINGS INC -- $673,859.20 1,072 BDCBC61
0.64% EXEL EXELIXIS INC -- $598,078.77 9,519 2576941
0.57% ASND ASCENDIS PHARMA A/S -- $535,956.30 2,365 BWXJHM8
0.57% NBIX NEUROCRINE BIOSCIENCES INC -- $534,789.75 3,905 2623911
0.57% JAZZ JAZZ PHARMACEUTICALS PLC -- $534,763.48 2,494 B4Q5ZN4
0.57% HALO HALOZYME THERAPEUTICS INC -- $529,783.60 4,360 2975098
0.55% BBIO BRIDGEBIO PHARMA INC -- $517,035.26 7,702 BK1KWG8
0.55% ONC BEONE MEDICINES LTD-ADR -- $515,108.16 1,377 BYYWPW6
0.51% TEM TEMPUS AI INC-CL A -- $479,273.94 6,738 BSLSJJ0
0.50% SMMT SUMMIT THERAPEUTICS INC -- $471,029.02 30,646 BMTVQS7
0.45% BMRN BIOMARIN PHARMACEUTICAL INC -- $416,787.80 7,436 2437071
0.44% MDGL MADRIGAL PHARMACEUTICALS INC -- $408,311.28 888 BD59BS7
0.44% IBRX IMMUNITYBIO INC -- $407,150.00 40,715 BNSP0B8
0.43% BNTX BIONTECH SE-ADR -- $401,209.60 4,448 BK6H543
0.40% KRYS KRYSTAL BIOTECH INC -- $375,210.00 1,137 BD6JX35
0.40% PCVX VAXCYTE INC -- $373,083.32 5,716 BKPVGH6
0.39% TWST TWIST BIOSCIENCE CORP -- $368,160.52 2,548 BGKG6G7
0.37% KYMR KYMERA THERAPEUTICS INC -- $345,399.16 3,194 BMPRZV5
0.37% CAI CARIS LIFE SCIENCES INC -- $344,786.56 10,856 BT18HP9
0.37% CYTK CYTOKINETICS INC -- $341,396.72 5,341 BBBSBJ5
0.36% PTGX PROTAGONIST THERAPEUTICS INC -- $339,463.30 2,486 BDCBCD8
0.36% TXG 10X GENOMICS INC-CLASS A -- $334,297.02 4,618 BKS3RS7
0.36% SNY SANOFI-ADR -- $333,681.78 8,282 2964557
0.35% AXSM AXSOME THERAPEUTICS INC -- $325,521.48 2,012 BYZR4X4
0.34% ARWR ARROWHEAD PHARMACEUTICALS IN -- $317,421.00 5,426 BYQBFJ8
0.30% IONS IONIS PHARMACEUTICALS INC -- $281,662.08 6,384 BDJ0LS6
0.29% SYRE SPYRE THERAPEUTICS INC -- $271,298.70 3,387 BQBBDY8
0.29% PRAX PRAXIS PRECISION MEDICINES I -- $266,361.52 1,073 BQ721R4
0.28% ALKS ALKERMES PLC -- $258,444.50 6,445 B3P6D26
0.28% AMRX AMNEAL PHARMACEUTICALS INC -- $257,565.00 13,380 BFNF1D6
0.27% IOVA IOVANCE BIOTHERAPEUTICS INC -- $256,142.72 17,401 BF0DMK7
0.25% RYTM RHYTHM PHARMACEUTICALS INC -- $232,680.65 2,645 BF2YWG4
0.25% GRAL GRAIL INC -- $232,449.36 1,716 BSLSSX7
0.25% LGND LIGAND PHARMACEUTICALS -- $228,651.00 766 2501578
0.23% IMVT IMMUNOVANT INC -- $218,291.85 7,935 BJRFSB7
0.23% KOD KODIAK SCIENCES INC -- $212,721.68 2,414 BFXC933
0.23% CGON CG ONCOLOGY INC -- $210,633.30 3,405 BRBCSP4
0.22% MIRM MIRUM PHARMACEUTICALS INC -- $205,480.66 2,494 BJDX8Y8
0.22% ABVX ABIVAX SA-ADR -- $202,866.48 2,196 BLC89B2
0.21% ERAS ERASCA INC -- $199,793.32 13,436 BNLYBF3
0.21% COGT COGENT BIOSCIENCES INC -- $196,713.66 6,666 BLR6XK8
0.21% PTCT PTC THERAPEUTICS INC -- $195,533.94 3,206 B17VCN9
0.21% CRSP CRISPR THERAPEUTICS AG -- $191,396.80 3,715 BDHF4K6
0.20% TVTX TRAVERE THERAPEUTICS INC -- $191,152.59 3,621 BLFGJD5
0.20% SRRK SCHOLAR ROCK HOLDING CORP -- $190,113.92 4,678 BFZQ0L8
0.20% ORKA ORUKA THERAPEUTICS INC -- $187,925.28 2,544 BKVF0J2
0.19% DFTX DEFINIUM THERAPEUTICS INC -- $176,850.12 5,162 BV2DHY6
0.17% EWTX EDGEWISE THERAPEUTICS INC -- $159,370.40 4,172 BKY5JZ8
0.17% ABCL ABCELLERA BIOLOGICS INC -- $157,853.32 12,449 BL53SR3
0.17% ADPT ADAPTIVE BIOTECHNOLOGIES -- $156,830.98 6,131 BJ5FZ74
0.16% INDV INDIVIOR PHARMACEUTICALS INC -- $152,433.08 4,534 BTZRLN8
0.16% KNSA KINIKSA PHARMACEUTICALS INTE -- $148,288.70 1,855 BRXB0C0
0.16% TNGX TANGO THERAPEUTICS INC -- $147,027.90 6,477 BP2P6L0
0.16% RLAY RELAY THERAPEUTICS INC -- $145,648.70 8,419 BN2R582
0.15% GMAB GENMAB A/S -SP ADR -- $140,879.50 3,725 BBC9WC7
0.15% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $140,523.90 4,829 BKX9VD3
0.15% VCYT VERACYTE INC -- $137,076.32 3,088 BFTWZY0
0.14% AMLX AMYLYX PHARMACEUTICALS INC -- $133,328.30 4,822 BPCK358
0.14% ACAD ACADIA PHARMACEUTICALS INC -- $130,460.49 6,619 2713317
0.14% XENE XENON PHARMACEUTICALS INC -- $127,707.60 3,720 BRJ3GY4
0.13% IDYA IDEAYA BIOSCIENCES INC -- $125,481.95 3,707 BK0VHF6
0.13% TARS TARSUS PHARMACEUTICALS INC -- $125,368.34 1,766 BMH5RL1
0.12% DNLI DENALI THERAPEUTICS INC -- $112,625.94 6,141 BD2B4V0
0.12% ELVN ENLIVEN THERAPEUTICS INC -- $110,713.95 2,815 BMFD115
0.12% DYN DYNE THERAPEUTICS INC -- $109,690.46 7,174 BN15WD1
0.11% NRIX NURIX THERAPEUTICS INC -- $99,475.65 3,987 BMVLGP2
0.11% PGEN PRECIGEN INC -- $98,960.03 13,754 BKM5C84
0.11% BEAM BEAM THERAPEUTICS INC -- $98,128.64 3,968 BK6L288
0.10% -- NEWAMSTERDAM PHARMA CO NV -- $94,687.04 4,592 BP8JSP4
0.10% MBX MBX BIOSCIENCES INC -- $93,813.50 1,850 BQXJKH2
0.10% ADMA ADMA BIOLOGICS INC -- $92,331.65 8,605 B9NSBM2
0.09% SUPN SUPERNUS PHARMACEUTICALS INC -- $88,359.81 2,233 B72ZBG4
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $85,609.99 2,237 BKSGZN7
0.09% RXRX RECURSION PHARMACEUTICALS-A -- $85,554.56 20,566 BM9FJ13
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $85,507.03 5,111 BFWLC09
0.09% IRON DISC MEDICINE INC -- $83,558.75 1,475 BMGJZJ8
0.09% FTRE FORTREA HOLDINGS INC -- $83,087.49 3,653 BRXYZ57
0.09% NVAX NOVAVAX INC -- $81,240.34 6,337 BJDQXG4
0.09% VCEL VERICEL CORP -- $80,686.34 1,967 BSBMN89
0.09% PHVS PHARVARIS NV -- $79,939.08 2,697 BMZ2X38
0.08% VERA VERA THERAPEUTICS INC -- $79,081.76 2,768 BL55460
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $78,732.34 9,817 2100362
0.08% AGIO AGIOS PHARMACEUTICALS INC -- $74,142.08 2,294 BCBVTX1
0.08% MLYS MINERALYS THERAPEUTICS INC -- $73,489.44 3,396 BP9N0G0
0.08% SRPT SAREPTA THERAPEUTICS INC -- $72,191.82 4,058 B8DPDT7
0.08% XERS XERIS BIOPHARMA HOLDINGS INC -- $70,530.28 7,004 BLR7H87
0.08% ZYME ZYMEWORKS INC -- $70,194.50 2,726 BPCQZY9
0.08% LEGN LEGEND BIOTECH CORP-ADR -- $70,052.40 3,538 BMX9K07
0.07% GPCR STRUCTURE THERAPEUTICS INC -- $69,876.31 3,149 BQS9486
0.07% ALVO ALVOTECH SA -- $68,992.83 12,993 BPNTJ34
0.07% URGN UROGEN PHARMA LTD -- $68,753.58 1,878 BZ7PJQ1
0.07% XNCR XENCOR INC -- $68,544.00 2,856 BGCYWN8
0.07% VIR VIR BIOTECHNOLOGY INC -- $68,065.47 6,501 BK4PZ38
0.07% SEPN SEPTERNA INC -- $67,147.85 1,793 BQNKXX2
0.07% TRVI TREVI THERAPEUTICS INC -- $66,278.03 5,473 BJH9ZN0
0.07% PSNL PERSONALIS INC -- $65,360.79 4,103 BJQ0608
0.07% NVCR NOVOCURE LTD -- $64,455.93 4,473 BYSS4X4
0.07% ANIP ANI PHARMACEUTICALS INC -- $63,750.96 882 BCDWBX6
0.07% ZBIO ZENAS BIOPHARMA INC -- $63,601.60 2,504 BQB42H3
0.07% OCUL OCULAR THERAPEUTIX INC -- $62,265.06 8,437 BNZB1X8
0.07% NTLA INTELLIA THERAPEUTICS INC -- $61,043.22 5,383 BYZM6C2
0.07% STOK STOKE THERAPEUTICS INC -- $61,008.19 2,479 BJQ05Z6
0.06% QURE UNIQURE NV -- $60,015.80 2,665 BJFSR88
0.06% CMPS COMPASS PATHWAYS PLC -- $59,773.28 5,144 BMC3HS7
0.06% MAZE MAZE THERAPEUTICS INC -- $58,642.32 2,134 BSRK699
0.06% ABSI ABSCI CORP -- $58,545.84 6,593 BN94K69
0.06% INVA INNOVIVA INC -- $57,886.50 2,775 BDDXF67
0.06% RARE ULTRAGENYX PHARMACEUTICAL IN -- $57,448.79 3,787 BJ62Z18
0.06% ETON ETON PHARMACEUTICALS INC -- $56,360.34 1,098 BGL0JK3
0.06% PCRX PACIRA BIOSCIENCES INC -- $55,621.23 1,531 B3X26D8
0.06% ANAB ANAPTYSBIO INC -- $55,383.27 1,137 BDRW1L7
0.06% RAPP RAPPORT THERAPEUTICS INC -- $54,497.51 1,843 BR3T9B6
0.06% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $52,474.40 1,780 BLCD809
0.06% OMER OMEROS CORP -- $52,254.99 2,781 B4NB858
0.05% INBX INHIBRX BIOSCIENCES INC -- $51,132.50 565 BNSP8K3
0.05% ORIC ORIC PHARMACEUTICALS INC -- $50,850.14 3,982 BKVDFF7
0.05% GHRS GH RESEARCH PLC -- $49,601.97 2,637 BP6C0S2
0.05% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $49,482.92 1,373 BS2CR64
0.05% SNDX SYNDAX PHARMACEUTICALS INC -- $46,819.50 3,430 BN7Q7R7
0.05% TSHA TAYSHA GENE THERAPIES INC -- $46,688.41 12,517 BNC1BX1
0.05% BCAX BICARA THERAPEUTICS INC -- $44,790.04 2,542 BQB42F1
0.05% VOR VOR BIOPHARMA INC -- $43,959.82 2,273 BRJJYT3
0.05% TYRA TYRA BIOSCIENCES INC -- $43,658.72 2,293 BMVNDH9
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $43,170.28 1,634 BNFWZS4
0.05% REPL REPLIMUNE GROUP INC -- $42,535.00 3,620 BDDVW37
0.04% HROW HARROW INC -- $41,400.00 1,440 BHNDW86
0.04% JANX JANUX THERAPEUTICS INC -- $40,684.68 2,349 BMFX8Y7
0.04% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $40,468.68 5,724 BMCWKZ2
0.04% ZLAB ZAI LAB LTD-ADR -- $40,249.12 1,712 BD9GVY0
0.04% CSTL CASTLE BIOSCIENCES INC -- $39,681.20 1,174 BKLCWZ3
0.04% MNKD MANNKIND CORP -- $39,402.88 12,352 BF081J4
0.04% SVRA SAVARA INC -- $37,412.82 7,893 BYXGN81
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $36,494.10 3,690 BFYQFJ2
0.04% GRFS GRIFOLS SA-ADR -- $35,339.98 4,687 B8K7T65
0.04% CGEM CULLINAN THERAPEUTICS INC -- $34,608.00 2,472 BM90J52
0.04% RIGL RIGEL PHARMACEUTICALS INC -- $33,925.50 718 BQD3J33
0.04% GLUE MONTE ROSA THERAPEUTICS INC -- $33,163.24 3,277 BP7KZP7
0.04% KURA KURA ONCOLOGY INC -- $33,154.60 3,418 BYZD465
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $32,608.29 7,601 BZ0QMB7
0.03% CRVS CORVUS PHARMACEUTICALS INC -- $31,835.20 3,232 BYP80F1
0.03% AVBP ARRIVENT BIOPHARMA INC -- $31,800.26 1,894 BMGTLY5
0.03% ALMS ALUMIS INC -- $31,373.32 4,972 BPLQG36
0.03% ARDX ARDELYX INC -- $31,303.71 9,573 BN89V40
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $30,801.78 811 BL95N25
0.03% GERN GERON CORP -- $30,357.63 24,681 2370381
0.03% COLL COLLEGIUM PHARMACEUTICAL INC -- $28,998.18 1,251 BX7RSN3
0.03% SANA SANA BIOTECHNOLOGY INC -- $28,462.50 11,500 BMFJJ97
0.03% MESO MESOBLAST LTD- SPON ADR -- $28,095.30 2,014 BQS7491
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $27,310.14 2,122 BKLXFX5
0.03% OABI OMNIAB INC -- $26,417.05 5,585 BN13S71
0.03% ANNX ANNEXON INC -- $26,218.80 7,283 BMVV9R5
0.03% CADL CANDEL THERAPEUTICS INC -- $26,195.40 2,940 BP0TQC5
0.03% AURA AURA BIOSCIENCES INC -- $25,258.56 3,984 BP81R42
0.03% DSGN DESIGN THERAPEUTICS INC -- $25,193.92 2,404 BMFK3H6
0.03% PRME PRIME MEDICINE INC -- $25,154.48 6,968 BPBJFM7
0.03% WVE WAVE LIFE SCIENCES INC -- $24,148.30 7,570 C08GM13
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $23,931.96 6,348 B3MZ6K5
0.03% SLDB SOLID BIOSCIENCES INC -- $23,643.06 4,119 BQHN6C7
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,425.87 2,281 BLFBZ32
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $23,404.36 11,941 B4N8MH9
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $23,310.00 3,108 BJLKVS6
0.02% OLMA OLEMA PHARMACEUTICALS INC -- $23,090.07 3,361 BMZ4LN0
0.02% CRMD CORMEDIX INC -- $22,335.24 2,994 BJ0LT31
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $20,861.16 1,983 B7F2TY6
0.02% CTMX CYTOMX THERAPEUTICS INC -- $20,174.11 8,371 BYWVTY5
0.02% ACRS ACLARIS THERAPEUTICS INC -- $19,735.95 5,655 BYV2W40
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $19,577.32 4,822 BYVQJ96
0.02% SGMT SAGIMET BIOSCIENCES INC-A -- $19,330.22 2,366 BP2NYN2
0.02% EOLS EVOLUS INC -- $19,205.09 2,537 BDRJH21
0.02% NGNE NEUROGENE INC -- $18,417.55 769 BS2F741
0.02% RGNX REGENXBIO INC -- $18,157.76 2,536 BZ0G875
0.02% ARVN ARVINAS INC -- $17,985.92 2,512 BDZ30Q0
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $17,784.48 13,272 BFZNYB7
0.02% ALT ALTIMMUNE INC -- $17,636.28 7,473 BFY7DC4
0.02% KMDA KAMADA LTD -- $17,351.28 2,216 B2Q9833
0.02% LKFT LAKEFRONT BIOTHERAPEUTIC-ADR -- $17,119.96 572 B292NQ7
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $16,876.75 1,805 BL5B6Z1
0.02% PRTA PROTHENA CORP PLC -- $16,762.00 1,972 B91XRN2
0.02% TECX TECTONIC THERAPEUTIC INC -- $15,996.30 751 BPBPCG8
0.02% TKNO ALPHA TEKNOVA INC -- $15,671.20 2,062 BP7L561
0.02% SPRY ARS PHARMACEUTICALS INC -- $15,547.40 3,820 BMCR7V2
0.02% EDIT EDITAS MEDICINE INC -- $14,396.00 5,900 BZ8FPH3
0.02% KYTX KYVERNA THERAPEUTICS INC -- $14,184.72 2,376 BSMLR16
0.01% AVIR ATEA PHARMACEUTICALS INC -- $13,956.93 3,081 BLN9Z50
0.01% AUTL AUTOLUS THERAPEUTICS PLC -- $13,254.32 7,706 BFMLGR4
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $13,253.66 2,309 BPRB2N7
0.01% CCCC C4 THERAPEUTICS INC -- $13,138.28 4,726 BKX9NQ0
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $12,834.93 1,119 B9L5200
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $12,306.84 1,092 BKC9SX3
0.01% FULC FULCRUM THERAPEUTICS INC -- $10,756.77 2,931 BJDX8Z9
0.01% EYPT EYEPOINT INC -- $10,399.68 3,312 BMGS7L1
0.01% CABA CABALETTA BIO INC -- $10,095.15 6,513 BK5MWR1
0.01% QSI QUANTUM-SI INC -- $10,012.33 7,643 BNR5QT9
0.01% CTNM CONTINEUM THERAPEUTICS INC-A -- $10,001.40 1,266 BPRBTY7
0.01% RCKT ROCKET PHARMACEUTICALS INC -- $9,952.12 4,217 BDFKQ07
0.01% VNDA VANDA PHARMACEUTICALS INC -- $9,849.52 2,323 B12W3P6
0.01% ACIU AC IMMUNE SA -- $9,579.50 3,910 BZC0D70
0.01% BIOA BIOAGE LABS INC -- $9,432.05 1,763 BT9K6D8
0.01% LFCR LIFECORE BIOMEDICAL INC -- $9,363.76 1,454 2517058
0.01% IMRX IMMUNEERING CORP - CLASS A -- $9,045.40 2,485 BMVBZF5
0.01% SIGA SIGA TECHNOLOGIES INC -- $8,804.40 2,760 2107437
0.01% LXEO LEXEO THERAPEUTICS INC -- $8,699.52 3,152 BQ6C357
0.01% KROS KEROS THERAPEUTICS INC -- $8,458.20 762 BM7V485
0.01% LRMR LARIMAR THERAPEUTICS INC -- $7,942.09 3,991 BMXNGZ6
0.01% LYEL LYELL IMMUNOPHARMA INC -- $7,706.79 941 BTNMG41
0.01% IVVD INVIVYD INC -- $7,572.82 11,323 BM8NHS1
0.01% TRDA ENTRADA THERAPEUTICS INC -- $7,150.88 1,496 BP81RK8
0.01% UPB UPSTREAM BIO INC -- $7,090.48 2,104 BRCFFK6
0.01% SION SIONNA THERAPEUTICS INC -- $7,086.96 1,737 BQKXDX4
0.01% PEPG PEPGEN INC -- $6,732.33 2,661 BMTX3D7
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $6,462.00 1,795 BKDQKM6
0.01% CHRS COHERUS ONCOLOGY INC -- $6,350.45 5,935 BRK0149
0.01% MENS JYONG BIOTECH LTD -- $5,783.58 2,921 BPTK6Z2
0.01% PYXS PYXIS ONCOLOGY INC -- $5,767.20 3,204 BLBR8D5
0.01% CDXS CODEXIS INC -- $5,721.52 4,207 B5LL2C2
0.01% NBP NOVABRIDGE BIOSCIENCES -- $5,562.48 4,312 BKRRKY7
0.01% AVXL ANAVEX LIFE SCIENCES CORP -- $5,270.28 3,561 BYTYP72
0.01% VYGR VOYAGER THERAPEUTICS INC -- $4,876.02 2,367 BY7RB53
0.01% HUMA HUMACYTE INC -- $4,690.34 10,672 BMYTJP4
-- FHTX FOGHORN THERAPEUTICS INC -- $4,311.09 2,281 BMF7DT9
-- LENZ LENZ THERAPEUTICS INC -- $4,308.99 1,207 BQV0J03
-- BDTX BLACK DIAMOND THERAPEUTICS I -- $3,840.18 2,207 BKTV702
-- TNYA TENAYA THERAPEUTICS INC -- $3,517.96 8,614 BNNXX52
-- AARD AARDVARK THERAPEUTICS INC -- $3,246.26 841 BTXQTX3
-- NMRA NEUMORA THERAPEUTICS INC -- $3,082.09 7,218 BN4JN37
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,015.12 4,434 BNNXX18
-- GOSS GOSSAMER BIO INC -- $2,089.15 235 C0BCTT5
-- CRBU CARIBOU BIOSCIENCES INC -- $1,913.63 4,118 BNYJR68
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- -- COHERUS ONCOLOGY INC COMMON STOCK USD -- $00.00 5,356 --
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
32.64% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 30,448,388 -- 4,347 --
31.15% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 29,061,505 -- 4,149 --
31.12% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 29,033,487 -- 4,145 --
19.82% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 18,484,770 -- 2,639 --
18.87% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 17,602,208 -- 2,513 --
4.72% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 4,405,805 -- 629 --
-- IQMM PROSHARES GENIUS MONEY MARKET ETF -- $17,013,600.00 170,000 BTGTPK8
-- -- NET OTHER ASSETS (LIABILITIES) -- $18,574,034.27 18,574,034 --

Index

as of 6/30/2026

  • Total Number of Holdings251
  • Price/Book Ratio5.57
  • Dividend Yield ( % )0.53
  • Avg. Index Market Capitalization$7.18 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.